Revenue
$33.99B
Fiscal year ended 2025-12-31Operating income
$8.92B
Fiscal year ended 2025-12-31Free cash flow
$5.09B
Fiscal year ended 2025-12-31LINDE PLC (LIN) reported revenue of $33.99B and net income of $6.90B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from LINDE PLC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Industrial Inorganic Chemicals.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33.99B | $33.00B | $32.85B | $33.36B | $30.79B | $27.24B | $28.23B | $14.84B | $11.36B | $10.53B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $8.92B | $8.64B | $8.02B | $5.37B | $4.98B | $3.32B | $2.93B | $5.25B | $2.44B | $2.25B |
| Net income | $6.90B | $6.56B | $6.20B | $4.15B | $3.83B | $2.50B | $2.28B | $4.38B | $1.25B | $1.50B |
| Research & development | $147.00M | $150.00M | $146.00M | $143.00M | $143.00M | $152.00M | $184.00M | $113.00M | $93.00M | $92.00M |
| Weighted-average diluted shares | shares 472.20M | shares 482.09M | shares 492.29M | shares 504.04M | shares 521.88M | shares 531.16M | shares 545.17M | shares 334.13M | shares 289.11M | shares 287.76M |
| Pretax income | $8.90B | $8.57B | $7.99B | $5.54B | $5.10B | $3.38B | $2.93B | $5.05B | $2.29B | $2.05B |
| Income tax expense | $1.99B | $2.00B | $1.81B | $1.43B | $1.26B | $847.00M | $769.00M | $817.00M | $1.03B | $551.00M |
| Diluted EPS | $14.61 | $13.62 | $12.59 | $8.23 | $7.33 | $4.71 | $4.19 | $13.11 | $4.32 | $5.21 |
| Selling, general & administrative | $3.43B | $3.34B | $3.30B | $3.11B | $3.19B | $3.19B | $3.46B | $1.63B | $1.21B | $1.14B |
| General & administrative | $2.08B | $2.00B | $1.96B | $1.81B | $1.85B | $1.89B | $1.86B | $872.00M | $696.00M | $652.00M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5.06B | $4.85B | $4.66B | $5.44B | $2.82B | $3.75B | $2.70B | $4.47B | $617.00M | $524.00M |
| Total assets | $86.82B | $80.15B | $80.81B | $79.66B | $81.60B | $88.23B | $86.61B | $93.39B | $20.44B | Unavailable |
| Current assets | $13.32B | $12.94B | $12.62B | $13.05B | $10.16B | $10.92B | $10.35B | $17.27B | $3.28B | Unavailable |
| Total liabilities | $47.08B | $40.66B | $39.72B | $38.27B | $36.16B | $38.65B | $34.98B | $36.29B | $13.91B | Unavailable |
| Current liabilities | $15.20B | $14.54B | $15.72B | $16.48B | $13.64B | $13.74B | $12.16B | $12.96B | $3.31B | Unavailable |
| Total equity incl. NCI | $39.73B | $39.48B | $41.08B | $41.37B | $45.43B | $49.57B | $51.52B | $57.08B | $6.51B | $5.44B |
| Temporary (mezzanine) equity | $13.00M | $13.00M | $13.00M | $13.00M | $13.00M | $13.00M | $113.00M | $16.00M | $11.00M | $11.00M |
| Inventory | $2.06B | $1.95B | $2.12B | $1.98B | $1.73B | $1.73B | $1.70B | $1.65B | $614.00M | Unavailable |
| Accounts receivable | $4.97B | $4.62B | $4.72B | $4.56B | $4.50B | $4.17B | $4.32B | $4.30B | $1.71B | Unavailable |
| Goodwill | $27.93B | $25.94B | $26.75B | $25.82B | $27.04B | $28.20B | $27.02B | $26.87B | $3.23B | $3.12B |
| Long-term debt | $20.68B | $15.34B | $13.40B | $12.20B | $11.34B | $12.15B | $10.69B | $12.29B | $7.78B | Unavailable |
| Accounts payable | $2.81B | $2.51B | $3.02B | $3.00B | $3.50B | $3.10B | $3.27B | $3.22B | $922.00M | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.35B | $9.42B | $9.30B | $8.86B | $9.72B | $7.43B | Unavailable | Unavailable | Unavailable | Unavailable |
| Capital expenditures | $5.26B | $4.50B | $3.79B | $3.17B | $3.09B | $3.40B | $3.68B | $1.88B | $1.31B | $1.46B |
| Investing cash flow | -$5.72B | -$4.64B | -$4.67B | -$3.09B | -$3.01B | -$2.99B | Unavailable | $5.36B | -$1.31B | -$1.77B |
| Financing cash flow | -$4.55B | -$4.36B | -$5.40B | -$3.09B | -$7.59B | -$3.34B | Unavailable | -$5.00B | -$1.66B | -$659.00M |
| Net change in cash | $206.00M | $186.00M | -$772.00M | $2.61B | -$931.00M | $1.05B | -$1.75B | $3.99B | $93.00M | $377.00M |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | $107.00M | $128.00M | $133.00M | $95.00M | $62.00M | $59.00M | $39.00M |
| Common dividends paid | $2.81B | $2.66B | $2.48B | $2.34B | $2.19B | $2.03B | $1.89B | $1.17B | $901.00M | $856.00M |
| Common share repurchases | $4.60B | $4.48B | $3.96B | $5.17B | $4.61B | $2.46B | $2.66B | $599.00M | $12.00M | $228.00M |
| Depreciation & amortization | $3.76B | $3.78B | $3.82B | $4.20B | $4.64B | $4.63B | $4.68B | $1.83B | $1.18B | $1.12B |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $5.09B | $4.93B | $5.52B | $5.69B | $6.64B | $4.03B | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 26.3% | 26.2% | 24.4% | 16.1% | 16.2% | 12.2% | 10.4% | 35.4% | 21.5% | 21.3% |
| FCF margin | 15.0% | 14.9% | 16.8% | 17.1% | 21.6% | 14.8% | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 0.5% | 0.3% | 0.4% | 0.5% | 0.4% |
| Current ratio | 0.88x | 0.89x | 0.80x | 0.79x | 0.74x | 0.80x | 0.85x | 1.33x | 0.99x | Unavailable |
| Revenue YoY growth | 3.0% | 0.5% | -1.5% | 8.3% | 13.0% | -3.5% | 90.3% | 30.6% | 7.8% | Unavailable |
| Net margin | 20.3% | 19.9% | 18.9% | 12.4% | 12.4% | 9.2% | 8.1% | 29.5% | 11.0% | 14.2% |
| R&D / revenue | 0.4% | 0.5% | 0.4% | 0.4% | 0.5% | 0.6% | 0.7% | 0.8% | 0.8% | 0.9% |
| CapEx / revenue | 15.5% | 13.6% | 11.5% | 9.5% | 10.0% | 12.5% | 13.0% | 12.7% | 11.5% | 13.9% |
| Long-term debt / equity | 0.52x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 22.4% | 23.4% | 22.7% | 25.9% | 24.7% | 25.0% | 26.3% | 16.2% | 44.9% | 26.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open LIN in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-02-25View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-01View SEC filing
10-Q · Filed 2025-05-01View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.